NPEC-caged-D-AP5

Discontinued Product

4230 has been discontinued.

View all Caged Glutamate Compounds products.
说明: Caged D-AP5 (Cat.No. 0106)
化学名: D-[[1-(2-Nitrophenyl)ethyl]carbamoyl]-2-amino]-5-phosphonopentanoic acid
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (3)

生物活性 for NPEC-caged-D-AP5

NPEC-caged-D-AP5 is a D-AP5 (Cat.No. 0106) caged with the photosensitive 1-(2-nitrophenyl)ethoxycarbonyl (NPEC) group. NMDA receptor antagonist.

技术数据 for NPEC-caged-D-AP5

分子量 390.28
公式 C14H19N2O9P
储存 Store at -20°C
纯度 ≥99% (HPLC)
CAS Number 1416943-27-5
PubChem ID 90488920
InChI Key RLEANJAZNZWLHC-HCCKASOXSA-N
Smiles O=C(OC(C)C1=CC=CC=C1[N+]([O-])=O)N[C@H](CCCP(O)(O)=O)C(O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for NPEC-caged-D-AP5

参考文献 for NPEC-caged-D-AP5

参考文献是支持产品生物活性的出版物。

Murphy et al (1997) Activation of NMDA receptors is necessary for the induction of associative long-term potentiation in area CA1 of the rat hippocampal slice. J.Physiol. 504 379 PMID: 9365912

关键词: NPEC-caged-D-AP5, NPEC-caged-D-AP5 supplier, caged-D-AP5, caged, compounds, photolysis, D-AP5, NMDA, antagonist, Caged, Glutamate, Compounds, Receptors, 4230, Tocris Bioscience

篇 NPEC-caged-D-AP5 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 NPEC-caged-D-AP5 的引用文献。

NPEC-caged-D-AP5 的评论

目前没有该产品的评论。 Be the first to review NPEC-caged-D-AP5 and earn rewards!

Have you used NPEC-caged-D-AP5?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.